Epione FDA Status Update

Epione Biopharmaceuticals recently completed an informal meeting with the FDA. Dr. Patricia Love, Deputy Director of Combination Devices Division at the FDA, met with the Epione team November 9, 2016. During the meeting, Dr. Love informally affirmed that the anticipated pathway using surrogate data on its existing APIs could allow approval in as little as 6-10 months.